Immunovia AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	0.79	0.93	1.58	1.15	0.84	0.36
Revenue	0.79	0.93	1.58	1.15	0.84	0.36
Revenue Growth (YoY)	24.37%	-40.89%	37.55%	35.66%	133.15%	1.69%
Cost of Revenue	0.04	-	6.68	4.21	-14.97	-40.02
Gross Profit	0.75	0.93	-5.11	-3.07	15.81	40.38
Selling, General & Admin	91.08	94.48	148.3	162.97	162.09	165.12
Other Operating Expenses	0.98	3.21	1.56	0.26	1.4	0.18
Operating Expenses	95	111.11	291.58	188.14	182.55	175.06
Operating Income	-94.25	-110.17	-296.69	-191.21	-166.74	-134.68
Interest Expense	-64.64	-1.86	-1.17	-1.6	-1.43	-1.42
Interest & Investment Income	33.25	34.73	6.28	0.75	0.71	0.58
Currency Exchange Gain (Loss)	0.76	0.76	-17.87	23.97	11.5	-10.51
Other Non Operating Income (Expenses)	-0.64	-	0.01	-	-	-
EBT Excluding Unusual Items	-125.52	-76.54	-309.44	-168.09	-155.97	-146.03
Pretax Income	-125.52	-76.54	-309.44	-168.09	-155.97	-146.03
Net Income	-125.52	-76.54	-309.44	-168.09	-155.97	-146.03
Net Income to Common	-125.52	-76.54	-309.44	-168.09	-155.97	-146.03
Shares Outstanding (Basic)	245	83	39	23	23	21
Shares Outstanding (Diluted)	245	83	39	23	23	21
Shares Change (YoY)	347.58%	112.20%	72.02%	-	6.05%	9.05%
EPS (Basic)	-0.51	-0.93	-7.95	-7.43	-6.89	-6.84
EPS (Diluted)	-0.52	-0.93	-7.95	-7.43	-6.89	-6.84
Free Cash Flow	-86.89	-96.75	-147.06	-176.84	-155.75	-124.7
Free Cash Flow Per Share	-0.35	-1.17	-3.78	-7.81	-6.88	-5.84
Gross Margin	95.42%	100.00%	-	-267.77%	1873.58%	11155.25%
Operating Margin	-11990.46%	-11833.94%	-18837.27%	-16699.48%	-19756.04%	-37203.87%
Profit Margin	-15968.96%	-8221.38%	-19646.92%	-14680.52%	-18479.38%	-40340.61%
Free Cash Flow Margin	-11055.22%	-10392.37%	-9336.95%	-15444.37%	-18453.67%	-34448.07%
EBITDA	-90.97	-96.42	-170.03	-185.15	-161.1	-130.41
D&A For EBITDA	3.27	13.75	126.66	6.06	5.64	4.27
EBIT	-94.25	-110.17	-296.69	-191.21	-166.74	-134.68
Revenue as Reported	0.91	1.69	1.8	1.2	0.96	0.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.